Video - Ratio calculation of Aβ1-42 and Aβ1-40 offers essential information about the buildup of amyloid pathology in a patient's brain
Sep 20, 2021
Early and accurate diagnosis of Alzheimer's disease helps patients manage their condition and lifestyle.
In vitro analysis of a few drops of cerebrospinal fluid - or CSF - gives the clinician immediate diagnostic insights, through the measurement of the four main biomarkers currently used to help diagnose Alzheimer's disease.
This 2 minute video explains why and how a ratio calculation of the two amyloid proteins, Aβ1-42 and Aβ1-40, offers particularly essential information about the buildup of amyloid pathology in a patient's brain.
Read more about the use of the Aβ1-42/Aβ1-40 ratio to improve accuracy of Alzheimer's disease diagnosis in this guidance document.
Related articles
Apr 3, 2023
Mar 4, 2023
Jan 4, 2023
Jan 4, 2023
Oct 10, 2022
Sep 20, 2022
Sep 20, 2022
Sep 20, 2022
Jun 13, 2022
May 18, 2022
Mar 16, 2022
Jan 31, 2022
Jan 10, 2022
Jan 7, 2022
Dec 16, 2021
Dec 16, 2021
Nov 19, 2021
Nov 18, 2021
Nov 18, 2021
Oct 29, 2021
Sep 21, 2021
Jun 23, 2021
Mar 16, 2020
Jan 20, 2020
Jan 9, 2020
Nov 22, 2019
Sep 30, 2019